Abstract: The present invention is directed to novel lyophilized pharmaceutical preparations comprising a cytotoxic dipeptides such as melphalan flufenamide and one or more excipient(s) selected from the group comprising a polysorbate; a polyethylene glycol; ?-cyclodextrin; ocyclodextrin; hydroxypropyl-?-cyclodextrin; sulfobutylether-?-cyclodextrin; lactose; benzyl alcohol; disodium succinate; propylene glycol; Cremophor EL; Dimethyl sulfoxide; D-mannitol; Trehalose; Sucrose and an amino acid. This preparation may be further formulated and is useful in cancer therapy.

Abstract: Disclosed are amide compounds, preparation method and uses thereof, specifically, the compounds represented by formula I or pharmaceutically acceptable salts, wherein R1, R2, R3, R4, R5, Q, X and n are defined as in the description. Also disclosed are a method for preparing the compounds of formula I, a composition containing the compounds, and the uses of the same in the preparation of medicaments for regulating blood lipid and/or preventing gallstone. The compounds of formula I disclosed in the present invention have stability in vitro, good solubility in the pharmaceutical organic solvents and favorable bioavailability in animals.

Abstract: In various embodiments, the present invention provides pharmaceutical compositions comprising fatty acids and methods for treating subjects using same.

Abstract: The present invention includes methods for producing and purifying esters of polyunsaturated fatty acids that include reacting a composition having triglycerides with polyunsaturated fatty acid residues in the presence of an alcohol and a base to produce an ester of a polyunsaturated fatty acid from the triglycerides. The composition can be a polyunsaturated fatty acid-containing composition that has not been conventionally processed. The reacted composition can be further processed by distillation.

Abstract: Described are compounds of the structural formula (I): Also provided are pharmacologically acceptable isomers and salts of the compound of (I). The compounds are useful in the treatment of inflammatory bowel disease.

Abstract: The present invention is directed to methods of using inhibitors of the cytosolic form of BCAT in the treatment of cancer, rheumatoid arthritis, and bone disease.

Abstract: The present invention relates to a topical film-forming composition for the treating dermatophytosis, specifically mycoses of the feet and, in particular, for treating the symptoms associated with dermatophytosis, specifically the symptoms associated with athlete's foot. The composition is particularly suitable for treating cracking, and for promoting the healing of skin lesions caused by said inflammation. The present composition is also suitable for preventing bacterial or fungal proliferation in the damaged skin.

Abstract: The present invention provides a compound of Formula I: as defined herein, or a pharmaceutically acceptable salt thereof.

Abstract: This invention relates to novel acetylcysteine compositions in solution, comprising acetylcysteine and which are substantially free of metal chelating agents, such as EDTA. Further, this invention relates to methods of making and using the acetylcysteine compositions. The present compositions and methods are designed to improve patient tolerance and compliance, while at the same time maintaining the stability of the pharmaceutical formulation. The compositions and methods of this invention are useful in the treatment of acetaminophen overdose, acute liver failure, various cancers, methacrylonitrile poisoning, reperfusion injury during cardio bypass surgery, and radiocontrast-induced nephropathy, and can also be used as a mucolytic agent.

Abstract: The present invention relates to novel dihydronaphthalene and naphthalene derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the N-formyl peptide receptor like-1 (FPRL-1) receptor.

Abstract: The present invention relates to the field of treatment and prevention of conditions related to oxidative stress and hormone resistance. Preferably, insulin resistance, erythropoietin resistance and acetyl-choline resistance are in the focus. The invention also relates to the field of use of amino acids, in particular p-L-Tyrosine and a precursor thereof as a medicament or composition or formulation in the prevention or treatment of said conditions.

Abstract: A compound of Formula (I): or a metabolite thereof, or an ester of the compound of Formula (I) or the metabolite thereof, or a pharmaceutically acceptable salt of each thereof, wherein m, n, X1 and X2 are as defined herein, is useful for treating non-alcoholic steatohepatitis (NASH) and/or reducing one or more of hepatic fibrosis, lobular inflammation, and hepatocellular ballooning.

Abstract: Treatment of CNS disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine; and (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine is disclosed. A process for preparing 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine is also disclosed. The process includes the preparation of all four isomers of N-[4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]formamide, which are also useful.

Abstract: A prophylactic, ameliorating or therapeutic agent for a retinal disease, the agent comprising geranylgeranylacetone which (a) is a mixture of (5E,9E,13E)-geranylgeranylacetone and (5Z,9E,13E)-geranylgeranylacetone, the (5E,9E,13E)-geranylgeranylacetone content of the mixture being 80% by weight or more, (b) consists of (5E,9E,13E)-geranylgeranylacetone, or (c) consists of (5Z,9E,13E)-geranylgeranylacetone directly suppresses the death of a retinal cell, thereby fundamentally preventing, ameliorating or treating the retinal disease.

Abstract: An implant having shape forming and hardening functionality is described. The implant is formed from shape memory materials. The implant is formed from a shape memory alloy, shape memory polymer, or combinations thereof, to provide them with the ability to be compressed into a shape that facilitates minimally invasive insertion. Subsequent to such insertion, the shape memory materials provide the implant with the ability to regain its original shape and size. Subsequently, the implant becomes rigid, thereby providing strength, structural integrity and support.

Abstract: The present invention is directed to immediate release film coating systems for use on oral dosage forms such as compressed tablets and other orally-ingestible substrates which have improved moisture barrier properties. The film coating systems can be applied either directly to a substrate or after the substrate has been coated with a subcoat. In preferred aspects, the moisture barrier film coating is prepared as a dry powder mixture containing polyvinyl alcohol, a polymer with pH dependent solubility, a plasticizer, a glidant, and, optionally, a detackifier, an alkalizing agent and a pigment. Film coating compositions containing an aqueous suspension of the powder mixtures, methods of applying the coatings to substrates and the coated substrates are also disclosed.

Abstract: Disclosed is a pharmaceutical composition comprising a water insoluble polymer matrix that comprises a bioerodable polyester polymer or a fatty acid based polyester polymer, or a mixture of both polymers, wherein the polymer matrix has a melting point of less than 60° C., and wherein the composition is liquid or paste at room temperature and is formulated to occlude a punctual channel in a subject and conforms to the shape of the canalicular or punctal channel.

Abstract: A composition including a surfactant and at least one alkyl glycoside and/or saccharide alkyl ester and a drug. The surfactant composition(s) when admixed with a drug is non-toxic and non-irritating, while stabilizing and increasing the bioavailability of the drug. The invention also provides compositions that enhance absorption of drugs via the oral, ocular, nasal, nasolacrimal, inhalation or pulmonary, oral cavity (sublingual or Buccal cell) or CSF delivery route of a patient, including but not limited to insulin, glucagon and exendin-4.

Abstract: Microfibrous cellulose (MFC) broths are provided having improved performance as compared to wet cake microfibrous cellulose (MFC) and powdered microfibrous cellulose (MFC). In embodiments, compositions having an effective amount of an MFC broth and an effective amount of a surfactant have an improved yield value as compared to a composition having a surfactant and a wet cake MFC, a powdered MFC, or a combination thereof at the same concentration as the MFC broth. Also, methods are provided for improving the yield value of surfactant compositions by adding an effective amount of a microfibrous cellulose broth to an effective amount of surfactant to provide a surfactant composition having a yield value that is higher than a composition having the surfactant and a wet cake MFC, a powdered MFC, or a combination thereof at the same concentration as the microfibrous cellulose broth.

Abstract: The present invention includes compounds having structural formula (I), or pharmaceutically acceptable salts, solvate, and/or ester thereof. These compounds are useful as sweet flavor modifiers. The present invention also includes compositions comprising the present compounds and methods of enhancing the sweet taste of ingestible compositions. Furthermore, the present invention provides methods for preparing the compounds.

Abstract: The present invention relates to improved hydrogel materials using water gellants that are comprised of polymer backbones P to which hydrogen bonding 4H-units are covalently attached via a hydrophobic linker L. Optionally, the hydrogel contains additional ingredients or additives. These new reversible hydrogels can easily be fine-tuned in their mechanical performance and function and are especially suitable for biomedical applications.

Abstract: A process for producing at least one product from at least one gaseous reactant includes feeding the gaseous reactant, as a gaseous feed or as part of a gaseous feed which is at an inlet superficial gas velocity of at least 0.5 m/s, into a vessel holding an expanded slurry bed of solid catalyst particles suspended in a suspension liquid so that the gaseous reactant can bubble upwardly through the slurry bed. The slurry bed has a catalyst loading of at least 20% by volume of degassed slurry. The gaseous reactant s allowed to react catalytically at a pressure above atmospheric pressure as the gaseous reactant bubbles upwardly through the slurry bed to produce at least one product. The product and any unreacted gaseous reactant are withdrawn from the vessel.

Abstract: Herein disclosed is a catalyst composition for producing organic compounds comprising (a) a catalyst that promotes the oxidative coupling of methane (OCM) and a methane steam reforming (MSR) catalyst, wherein the catalyst composition causes oxidative dehydrogenation to form reactive species and oligomerization of the reactive species to produce the organic compounds; or (b) a catalyst that promotes syngas generation (SG) and a Fischer-Tropsch (FT) catalyst wherein the catalyst composition causes non-oxidative dehydrogenation to form reactive species and oligomerization of the reactive species to produce the organic compounds; or (c) a SG catalyst, a MSR catalyst, and a FT catalyst wherein the catalyst composition causes non-oxidative dehydrogenation to form reactive species and oligomerization of the reactive species to produce the organic compounds; or (d) a FT catalyst and a MSR catalyst wherein the catalyst composition causes reforming reactions and chain growing reactions to produce the organic compounds.

Abstract: Herein disclosed is a reactor comprising a housing; an inlet tube having a section with perforations along its length, wherein the inlet tube section is within the reactor housing; an outlet tube having a section with perforations along its length, wherein the outlet tube section is within the reactor housing; and at least one cylinder made of sintered metal contained within the reactor housing, wherein the sintered metal is catalytically active. In some cases, the sintered metal in the reactor comprises a porous metallic multifunctional (PMM) catalyst. Other reactor designs and the method of use are also described herein.

Abstract: The present invention relates to a process for producing ethylene and propylene from syngas, the process comprising the steps of a) contacting syngas (2) with a first catalyst composition to obtain a first product stream (3) comprising ethylene, propylene and aliphatic hydrocarbons having 4 or more carbon atoms, b) splitting the first product stream (3) into a second product stream (5) comprising at least 90% of said aliphatic hydrocarbons having 4 or more carbon atoms and a third product stream (4) comprising ethylene and propylene, c) separating ethylene and propylene in the third product stream so as to form a first ethylene stream (17) and a first propylene stream (16) and d) converting the second product stream (5) into a fourth product stream (8) comprising ethylene and/or propylene.

Abstract: In one embodiment, the invention is to an ion exchange resin composition comprising a metal-functionalized exchange resin comprising from 3% to 94% metal-functionalized active sites; and a non-metal-functionalized exchange resin comprising non-metal-functionalized active sites.

Abstract: Aerogel particles are impregnated with a volatile liquid. Organic polymer foams are made in the presence of the impregnated aerogel particles. The volatile liquid volatilizes during the foaming process, resulting in a composite foam in which the dispersed aerogel particle are filled with gas. The composite foams have exceptionally low thermal conductivities.

Abstract: The invention relates to flame-retardant expandable polymers and to polymer foams and to the use thereof. According to the invention, at least one of the following phosphorus compounds is used as a flame retardant: phosphorus compound according to formula (Ia): (Ia) 10-hydroxy-9, 10-dihydro-9-oxa-10-phosphaphenanthrene-10-oxide (DOPO-OH); or the salts thereof according to formula (Ib): (Ib) (DOPO-OR); or the ring-opened hydrolysates thereof according to formula (Ic): (Ic).

Abstract: The present invention relates to a foam rubber material for a weather strip comprising a crosslinked rubber sponge material having a load value ratio satisfying the following relationship: load value ratio (%)=B/A×100?50, wherein A is a load value at 50% compression in the course of compression deformation, and B is a load value at 50% compression in the course of returning from the deformation.

Abstract: A polyurethane foam having excellent shape-following properties, which exhibits favorable comfort when worn on the human body, both during movement and at rest. The polyurethane foam contains a toluene diisocyanate and a polyether polyol as the main components, has a glass transition temperature, defined as the temperature corresponding with the peak value of the loss tangent, of not less than 0° C. and not more than 40° C., and in the temperature range from not less than 0° C. to not more than 40° C., the loss tangent in the frequency range from not less than 0.1 Hz to not more than 100 Hz is 0.4 or greater, and the average value of the loss tangent in the frequency range from not less than 0.1 Hz to not more than 1 Hz is not greater than the average value of the loss tangent in the frequency range from not less than 10 Hz to not more than 100 Hz.

Abstract: The present invention relates to polyurethanes resulting from a reaction that includes a hydroxyalkanoate crosslinking agent. Methods of making polyurethanes are further described.

Abstract: The present invention aims to provide a method for modifying a surface of a rubber vulcanizate or a thermoplastic elastomer, which can impart excellent sliding properties and excellent durability against repeated sliding motion, and allow the surface to maintain the sealing properties, without using expensive self-lubricating resins. The present invention relates to a method for modifying a surface of an object of a rubber vulcanizate or a thermoplastic elastomer, the method including: Step 1 of forming polymerization initiation points on the surface of the object; and Step 2 of radical-polymerizing a monomer starting from the polymerization initiation points to grow polymer chains on the surface of the object.

Abstract: Compositions and methods for adjustable lenses are provided. In some embodiments, the lenses contain a lens matrix material, a masking compound, and a prepolymer. The lens matrix material provides structure to the lens. The masking compound is capable of blocking polymerization or crosslinking of the prepolymer, until photoisomerization of the compound is triggered, and the compound is converted from a first isomer to a second isomer having a different absorption profile. The prepolymer is a composition that can undergo a polymerization or crosslinking reaction upon photoinitiation to alter one or more of the properties of the lenses.

Abstract: A method for the preparation of an organic-inorganic hybrid composition is performed through three major steps. In addition, a product is generated from this organic-inorganic hybrid composition. In step one, a series of hydrolysis reactions and condensation reactions with a functional organosilane or a combination of functional organosilanes, in presence of water as a reactant for hydrolysis and a suitable acid or a base as a catalyst is performed in order to obtain the first intermediate. In step two, a hydroxyl group-capping intermediate is prepared via reacting a hydroxyl reactable chemical with a hydroxyl functional polymerizable compound. In the third step, a hydroxyl group-capping reaction is conducted with the first intermediate and the hydroxyl group-capping intermediate, so as to obtain the organic-inorganic hybrid composition. It may further include a polymerization step to form an organic-inorganic hybrid polymer composition by UV irradiation or other approaches.

Abstract: Provided is an ultraviolet-curable ink jet ink composition with excellent curability and storage stability, the composition containing a monomer A represented by Formula (I): CH2?CR1—COOR2—O—CH?CH—R3 (wherein R1 represents a hydrogen atom or a methyl group, R2 represents a C2-C20 divalent organic residue, and R3 represents a hydrogen atom or a C1-C11 monovalent organic residue); a (meth)acrylated amine compound; a hindered amine compound other than the (meth)acrylated amine compound; and a photopolymerization initiator.

Abstract: A bioadherent substrate includes a medical gel or medical gel precursor having a plurality of reactive members of a specific binding pair attached on or adapted to be attached to a surface of the medical gel, said reactive members being capable of forming covalent bonds with a plurality of complementary reactive members of the specific binding pair via a reaction selected from a Huisgen cycloaddition reaction, a Diels-Alder reaction and a thiol-ene reaction.

Abstract: A method for manufacturing a tire member, that improves various performances such as abrasion resistance, tear strength, fatigue resistance and the like of the tire member in good balance is provided. The method includes a step (A) for mixing at least a rubber component, a filler and a thiosulfuric acid compound containing an amino group, and a step (B) for mixing the mixture obtained by the step (A), a sulfur component, and a vulcanization accelerator, wherein the thiosulfuric acid compound containing an amino group is added in an amount of 0.2 parts by mass or more to 100 parts by mass of the rubber component in the step (A), and a temperature of the mixture during mixing is maintained within a range of from 145 to 170° C. for 20 seconds or more in the step (A).

Abstract: A rubber composition for the manufacture of tyres is based on one or more diene elastomers, one or more reinforcing fillers, and a vulcanization system. The vulcanization system includes one or more thiazole compounds chosen from compounds having the following formula (I): Certain specific thiazole derivatives are described.

Abstract: A resin composition which overcomes the defects of needle-like basic magnesium sulfate and has good balance among mechanical strength, molding productivity and the appearance of a molded article. The resin composition comprises (i) 100 parts by weight of a resin (component A), (ii) plate-like magnesium hydroxide having a crystal thickness (y) of 0.2 ?m or less and an aspect ratio of 20 to 100 (component B) and (iii) needle-like basic magnesium sulfate (component C), wherein the total content of the components B and C is 1 to 100 parts by weight based on 100 parts by weight of the resin, and the weight ratio of the component B to the component C is 0.1 to 0.9:0.9 to 0.1.

Abstract: In a fibrous planar structure in which fibers are embedded in a matrix, an increase in mechanical resistance is achieved by improving the adhesion between the fiber and the matrix.

Abstract: The invention relates to a modified nanoparticle including a nanoparticle and a diblock copolymer covalently attached to the nanoparticle, the diblock copolymer comprising a first block polymer of molecular weight greater than 1000 attached to the nanoparticle and a second block polymer of molecular weight greater than 1000 covalently linked to the first block polymer, wherein at least one of the first block polymer and second block polymer comprises repeating units having an azide, acetylene or triazole side chain. Nanocomposites incorporating modified nanoparticles, as well as methods of making modified nanoparticles and nanocomposites are also disclosed.

Abstract: Cured epoxy resins are widespread on account of their outstanding mechanical and chemical properties. It is common to use epoxy resins based on bisphenol A diglycidyl ether or bisphenol F diglycidyl ether, but for many sectors these are problematic because of their endocrine effect. The present invention relates to 2-phenyl-1,3-propanediol diglycidyl ether derivates and to curable epoxy resin compositions based thereon, as alternatives to the bisphenol A or bisphenol F diglycidyl ethers and to the epoxy resin compositions based thereon.

Abstract: Polymer compositions are described containing a thermoplastic polymer in combination with one or more components, such as a white pigment and optionally one or more reinforcing fillers. In one embodiment, the polymer composition can be formulated to have high reflective properties. In other embodiments, the polymer composition can be formulated so as to have desired melt flow characteristics. In still another embodiment, the polymer composition can be formulated so as to have desired mechanical properties, such as impact resistance.

Abstract: An epoxy resin molding material for sealing includes (A) an epoxy resin, (B) a curing agent, (C) a curing accelerator, (D) an inorganic filler, (E1) an arylamino group-containing alkoxysilane compound, and (E2) an epoxy group-containing alkoxy silane compound.

Abstract: The present invention concerns low-odor, low-viscosity hardeners for epoxy resins, including an amine with at least one amino group of formula (I) and an amine with at least one amino group of formula (II), wherein the amino groups of formulas (I) and (II) are present in a particular ratio. These hardeners harden quickly with epoxy resins and without blushing to form films of high hardness and good resistance. They are especially suitable for low-emission coatings.

Abstract: The present invention relates to a curing agent for moisture-curing compositions which includes at least one aqueous emulsion of at least one epoxy resin. Curing agents according to the invention are especially used for the accelerated curing of moisture-curing compositions which are based on polyurethane polymers that have isocyanate groups or of silane-functional polymers.

Abstract: A non-aqueous dispersion comprising a continuous phase and a dispersed phase, wherein the dispersed phase comprises the dispersion polymerization reaction product prepared from a reaction mixture comprising an ethylenically unsaturated monomer, an acrylic polymer stabilizer, and an aliphatic polyester stabilized seed polymer, is disclosed. Related coatings and coated substrates are also disclosed.

Abstract: Embodiments include a curable composition comprising an epoxy resin, a non-halogen flame retardant agent comprising at least two of an aryl-cyanato group and at least two of a phosphorus group, and a styrene and maleic anhydride copolymer. Embodiments include method of preparing the curable composition, prepregs that include a reinforcement component and the curable composition, and an electrical laminate formed with the curable composition.

Abstract: A resin composition prepared by blending an epoxy compound represented by the following formula (1), an acid anhydride, and a curing accelerator, wherein the epoxy compound is purified in such a way that, in a chromatogram obtained by gas chromatographic analysis, a ratio of a peak area B of peaks derived from a heavier molecular mass portion having longer retention times than the epoxy compound to a peak area A of peak(s) derived from the epoxy compound B/A is 2.0×10?3 or less. [In the formula, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, and R12 each independently represent a hydrogen atom, a halogen atom, an alkyl group which may have a substituent, or an alkoxy group which may have a substituent.

Abstract: The invention relates to thermosetting compositions containing isocyanurate ring(s) prepared through chain extension of an epoxy resin (a) with carboxyl-functional oligomers (b), which are the reaction product of polyols (i) containing one or more isocyanurate ring(s) and polycarboxylic acids or their anhydrides (ii). The polyols (i) containing one or more isocyanurate ring(s) can be prepared from the reactions of tris (2-hydroxyalkyl) isocyanurates with a modifier from a caprolactone or alkylene oxide, or glycidyl ester or glycidyl ether and mixtures thereof. The epoxy-functional thermosetting compositions containing an isocyanurate ring(s) can be further reacted with unsaturated acids, preferably (meth)acrylic acid, to obtain a curable polyacrylate. Both epoxy-functional isocyanurate and acrylate-functional isocyanurate thermosetting compositions can be further modified with a polyisocyanate to produce a composition that is useful as a reactive adhesive, binder or in other applications.